nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CYP2D6—Fingolimod—multiple sclerosis	0.106	0.148	CbGbCtD
Fesoterodine—ABCB1—Methylprednisolone—multiple sclerosis	0.0727	0.101	CbGbCtD
Fesoterodine—CYP3A4—Fingolimod—multiple sclerosis	0.0676	0.0938	CbGbCtD
Fesoterodine—ABCB1—Mitoxantrone—multiple sclerosis	0.053	0.0736	CbGbCtD
Fesoterodine—ABCB1—Betamethasone—multiple sclerosis	0.0473	0.0656	CbGbCtD
Fesoterodine—ABCB1—Prednisolone—multiple sclerosis	0.0466	0.0647	CbGbCtD
Fesoterodine—ABCB1—Prednisone—multiple sclerosis	0.044	0.0611	CbGbCtD
Fesoterodine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0436	0.0604	CbGbCtD
Fesoterodine—CYP3A4—Triamcinolone—multiple sclerosis	0.033	0.0458	CbGbCtD
Fesoterodine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0318	0.0441	CbGbCtD
Fesoterodine—CYP3A4—Betamethasone—multiple sclerosis	0.0283	0.0393	CbGbCtD
Fesoterodine—CYP3A4—Prednisolone—multiple sclerosis	0.0279	0.0388	CbGbCtD
Fesoterodine—ABCB1—Dexamethasone—multiple sclerosis	0.0275	0.0382	CbGbCtD
Fesoterodine—CYP3A4—Prednisone—multiple sclerosis	0.0264	0.0366	CbGbCtD
Fesoterodine—CYP2D6—Dexamethasone—multiple sclerosis	0.0259	0.036	CbGbCtD
Fesoterodine—ABCB1—Methotrexate—multiple sclerosis	0.0221	0.0307	CbGbCtD
Fesoterodine—CYP3A4—Dexamethasone—multiple sclerosis	0.0165	0.0229	CbGbCtD
Fesoterodine—Chest pain—Cladribine—multiple sclerosis	0.000941	0.00448	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000934	0.00445	CcSEcCtD
Fesoterodine—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00093	0.00443	CcSEcCtD
Fesoterodine—Confusional state—Cladribine—multiple sclerosis	0.000909	0.00433	CcSEcCtD
Fesoterodine—Dry skin—Prednisolone—multiple sclerosis	0.000907	0.00432	CcSEcCtD
Fesoterodine—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.000903	0.0043	CcSEcCtD
Fesoterodine—Infection—Cladribine—multiple sclerosis	0.000896	0.00427	CcSEcCtD
Fesoterodine—Nervous system disorder—Cladribine—multiple sclerosis	0.000884	0.00421	CcSEcCtD
Fesoterodine—Tachycardia—Cladribine—multiple sclerosis	0.00088	0.00419	CcSEcCtD
Fesoterodine—Skin disorder—Cladribine—multiple sclerosis	0.000876	0.00417	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Methotrexate—multiple sclerosis	0.000875	0.00417	CcSEcCtD
Fesoterodine—Insomnia—Cladribine—multiple sclerosis	0.000816	0.00388	CcSEcCtD
Fesoterodine—Somnolence—Cladribine—multiple sclerosis	0.000802	0.00382	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.000801	0.00381	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000779	0.00371	CcSEcCtD
Fesoterodine—Fatigue—Cladribine—multiple sclerosis	0.000777	0.0037	CcSEcCtD
Fesoterodine—Constipation—Cladribine—multiple sclerosis	0.000771	0.00367	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00076	0.00362	CcSEcCtD
Fesoterodine—Dry skin—Dexamethasone—multiple sclerosis	0.000757	0.0036	CcSEcCtD
Fesoterodine—Dry skin—Betamethasone—multiple sclerosis	0.000757	0.0036	CcSEcCtD
Fesoterodine—Feeling abnormal—Cladribine—multiple sclerosis	0.000743	0.00354	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000737	0.00351	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.000731	0.00348	CcSEcCtD
Fesoterodine—Infection—Azathioprine—multiple sclerosis	0.000728	0.00347	CcSEcCtD
Fesoterodine—Urticaria—Cladribine—multiple sclerosis	0.000716	0.00341	CcSEcCtD
Fesoterodine—Abdominal pain—Cladribine—multiple sclerosis	0.000713	0.00339	CcSEcCtD
Fesoterodine—Skin disorder—Azathioprine—multiple sclerosis	0.000712	0.00339	CcSEcCtD
Fesoterodine—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000711	0.00339	CcSEcCtD
Fesoterodine—Back pain—Mitoxantrone—multiple sclerosis	0.000703	0.00335	CcSEcCtD
Fesoterodine—Infestation—Methylprednisolone—multiple sclerosis	0.0007	0.00333	CcSEcCtD
Fesoterodine—Infestation NOS—Methylprednisolone—multiple sclerosis	0.0007	0.00333	CcSEcCtD
Fesoterodine—Face oedema—Prednisone—multiple sclerosis	0.000694	0.00331	CcSEcCtD
Fesoterodine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000684	0.00326	CcSEcCtD
Fesoterodine—Hypersensitivity—Cladribine—multiple sclerosis	0.000664	0.00316	CcSEcCtD
Fesoterodine—Dry skin—Prednisone—multiple sclerosis	0.000659	0.00314	CcSEcCtD
Fesoterodine—Asthenia—Cladribine—multiple sclerosis	0.000647	0.00308	CcSEcCtD
Fesoterodine—Pruritus—Cladribine—multiple sclerosis	0.000638	0.00304	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000634	0.00302	CcSEcCtD
Fesoterodine—Cough—Mitoxantrone—multiple sclerosis	0.000634	0.00302	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000633	0.00301	CcSEcCtD
Fesoterodine—Chest pain—Mitoxantrone—multiple sclerosis	0.000618	0.00294	CcSEcCtD
Fesoterodine—Diarrhoea—Cladribine—multiple sclerosis	0.000617	0.00294	CcSEcCtD
Fesoterodine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000604	0.00288	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.0006	0.00286	CcSEcCtD
Fesoterodine—Confusional state—Mitoxantrone—multiple sclerosis	0.000598	0.00285	CcSEcCtD
Fesoterodine—Dizziness—Cladribine—multiple sclerosis	0.000596	0.00284	CcSEcCtD
Fesoterodine—Infection—Mitoxantrone—multiple sclerosis	0.000589	0.0028	CcSEcCtD
Fesoterodine—Eye disorder—Methylprednisolone—multiple sclerosis	0.000587	0.00279	CcSEcCtD
Fesoterodine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000583	0.00278	CcSEcCtD
Fesoterodine—Abdominal pain—Azathioprine—multiple sclerosis	0.00058	0.00276	CcSEcCtD
Fesoterodine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000579	0.00275	CcSEcCtD
Fesoterodine—Skin disorder—Mitoxantrone—multiple sclerosis	0.000576	0.00274	CcSEcCtD
Fesoterodine—Rash—Cladribine—multiple sclerosis	0.000569	0.00271	CcSEcCtD
Fesoterodine—Dermatitis—Cladribine—multiple sclerosis	0.000568	0.00271	CcSEcCtD
Fesoterodine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000566	0.0027	CcSEcCtD
Fesoterodine—Headache—Cladribine—multiple sclerosis	0.000565	0.00269	CcSEcCtD
Fesoterodine—Vision blurred—Prednisolone—multiple sclerosis	0.000562	0.00267	CcSEcCtD
Fesoterodine—Mental disorder—Methylprednisolone—multiple sclerosis	0.00055	0.00262	CcSEcCtD
Fesoterodine—Angioedema—Prednisolone—multiple sclerosis	0.000544	0.00259	CcSEcCtD
Fesoterodine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00054	0.00257	CcSEcCtD
Fesoterodine—Dysgeusia—Triamcinolone—multiple sclerosis	0.000537	0.00256	CcSEcCtD
Fesoterodine—Nausea—Cladribine—multiple sclerosis	0.000536	0.00255	CcSEcCtD
Fesoterodine—Vertigo—Prednisolone—multiple sclerosis	0.000535	0.00255	CcSEcCtD
Fesoterodine—Eye disorder—Dexamethasone—multiple sclerosis	0.000534	0.00254	CcSEcCtD
Fesoterodine—Eye disorder—Betamethasone—multiple sclerosis	0.000534	0.00254	CcSEcCtD
Fesoterodine—Back pain—Triamcinolone—multiple sclerosis	0.00053	0.00252	CcSEcCtD
Fesoterodine—Somnolence—Mitoxantrone—multiple sclerosis	0.000527	0.00251	CcSEcCtD
Fesoterodine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000522	0.00248	CcSEcCtD
Fesoterodine—Fatigue—Mitoxantrone—multiple sclerosis	0.000511	0.00243	CcSEcCtD
Fesoterodine—Constipation—Mitoxantrone—multiple sclerosis	0.000507	0.00241	CcSEcCtD
Fesoterodine—Diarrhoea—Azathioprine—multiple sclerosis	0.000502	0.00239	CcSEcCtD
Fesoterodine—Angioedema—Triamcinolone—multiple sclerosis	0.000501	0.00238	CcSEcCtD
Fesoterodine—Angioedema—Methylprednisolone—multiple sclerosis	0.0005	0.00238	CcSEcCtD
Fesoterodine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000498	0.00237	CcSEcCtD
Fesoterodine—Vertigo—Triamcinolone—multiple sclerosis	0.000492	0.00234	CcSEcCtD
Fesoterodine—Vertigo—Methylprednisolone—multiple sclerosis	0.000491	0.00234	CcSEcCtD
Fesoterodine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000488	0.00233	CcSEcCtD
Fesoterodine—Dysuria—Methotrexate—multiple sclerosis	0.000486	0.00231	CcSEcCtD
Fesoterodine—Dizziness—Azathioprine—multiple sclerosis	0.000485	0.00231	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000485	0.00231	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000483	0.0023	CcSEcCtD
Fesoterodine—Cough—Triamcinolone—multiple sclerosis	0.000478	0.00228	CcSEcCtD
Fesoterodine—Tachycardia—Prednisolone—multiple sclerosis	0.000475	0.00226	CcSEcCtD
Fesoterodine—Urticaria—Mitoxantrone—multiple sclerosis	0.000471	0.00224	CcSEcCtD
Fesoterodine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000469	0.00223	CcSEcCtD
Fesoterodine—Eye disorder—Prednisone—multiple sclerosis	0.000465	0.00221	CcSEcCtD
Fesoterodine—Infestation NOS—Methotrexate—multiple sclerosis	0.000463	0.0022	CcSEcCtD
Fesoterodine—Infestation—Methotrexate—multiple sclerosis	0.000463	0.0022	CcSEcCtD
Fesoterodine—Rash—Azathioprine—multiple sclerosis	0.000462	0.0022	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000462	0.0022	CcSEcCtD
Fesoterodine—Dermatitis—Azathioprine—multiple sclerosis	0.000462	0.0022	CcSEcCtD
Fesoterodine—Headache—Azathioprine—multiple sclerosis	0.000459	0.00219	CcSEcCtD
Fesoterodine—Dry mouth—Triamcinolone—multiple sclerosis	0.000456	0.00217	CcSEcCtD
Fesoterodine—Angioedema—Dexamethasone—multiple sclerosis	0.000454	0.00216	CcSEcCtD
Fesoterodine—Angioedema—Betamethasone—multiple sclerosis	0.000454	0.00216	CcSEcCtD
Fesoterodine—Confusional state—Methylprednisolone—multiple sclerosis	0.00045	0.00214	CcSEcCtD
Fesoterodine—Vertigo—Betamethasone—multiple sclerosis	0.000447	0.00213	CcSEcCtD
Fesoterodine—Vertigo—Dexamethasone—multiple sclerosis	0.000447	0.00213	CcSEcCtD
Fesoterodine—Infection—Triamcinolone—multiple sclerosis	0.000444	0.00212	CcSEcCtD
Fesoterodine—Infection—Methylprednisolone—multiple sclerosis	0.000443	0.00211	CcSEcCtD
Fesoterodine—Insomnia—Prednisolone—multiple sclerosis	0.00044	0.00209	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000438	0.00209	CcSEcCtD
Fesoterodine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000438	0.00208	CcSEcCtD
Fesoterodine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000437	0.00208	CcSEcCtD
Fesoterodine—Tachycardia—Triamcinolone—multiple sclerosis	0.000436	0.00208	CcSEcCtD
Fesoterodine—Mental disorder—Prednisone—multiple sclerosis	0.000436	0.00208	CcSEcCtD
Fesoterodine—Nausea—Azathioprine—multiple sclerosis	0.000436	0.00207	CcSEcCtD
Fesoterodine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000435	0.00207	CcSEcCtD
Fesoterodine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000433	0.00206	CcSEcCtD
Fesoterodine—Asthenia—Mitoxantrone—multiple sclerosis	0.000425	0.00203	CcSEcCtD
Fesoterodine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000411	0.00195	CcSEcCtD
Fesoterodine—Vision blurred—Prednisone—multiple sclerosis	0.000408	0.00194	CcSEcCtD
Fesoterodine—Urethral disorder—Methotrexate—multiple sclerosis	0.000407	0.00194	CcSEcCtD
Fesoterodine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000406	0.00193	CcSEcCtD
Fesoterodine—Insomnia—Triamcinolone—multiple sclerosis	0.000404	0.00193	CcSEcCtD
Fesoterodine—Insomnia—Methylprednisolone—multiple sclerosis	0.000404	0.00192	CcSEcCtD
Fesoterodine—Infection—Dexamethasone—multiple sclerosis	0.000403	0.00192	CcSEcCtD
Fesoterodine—Infection—Betamethasone—multiple sclerosis	0.000403	0.00192	CcSEcCtD
Fesoterodine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000401	0.00191	CcSEcCtD
Fesoterodine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000398	0.00189	CcSEcCtD
Fesoterodine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000398	0.00189	CcSEcCtD
Fesoterodine—Tachycardia—Dexamethasone—multiple sclerosis	0.000396	0.00189	CcSEcCtD
Fesoterodine—Tachycardia—Betamethasone—multiple sclerosis	0.000396	0.00189	CcSEcCtD
Fesoterodine—Angioedema—Prednisone—multiple sclerosis	0.000396	0.00188	CcSEcCtD
Fesoterodine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000394	0.00187	CcSEcCtD
Fesoterodine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000393	0.00187	CcSEcCtD
Fesoterodine—Vertigo—Prednisone—multiple sclerosis	0.000389	0.00185	CcSEcCtD
Fesoterodine—Eye disorder—Methotrexate—multiple sclerosis	0.000388	0.00185	CcSEcCtD
Fesoterodine—Urticaria—Prednisolone—multiple sclerosis	0.000386	0.00184	CcSEcCtD
Fesoterodine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000386	0.00184	CcSEcCtD
Fesoterodine—Fatigue—Triamcinolone—multiple sclerosis	0.000386	0.00184	CcSEcCtD
Fesoterodine—Fatigue—Methylprednisolone—multiple sclerosis	0.000385	0.00183	CcSEcCtD
Fesoterodine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000375	0.00178	CcSEcCtD
Fesoterodine—Rash—Mitoxantrone—multiple sclerosis	0.000374	0.00178	CcSEcCtD
Fesoterodine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000373	0.00178	CcSEcCtD
Fesoterodine—Headache—Mitoxantrone—multiple sclerosis	0.000371	0.00177	CcSEcCtD
Fesoterodine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000369	0.00175	CcSEcCtD
Fesoterodine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000368	0.00175	CcSEcCtD
Fesoterodine—Insomnia—Dexamethasone—multiple sclerosis	0.000367	0.00175	CcSEcCtD
Fesoterodine—Insomnia—Betamethasone—multiple sclerosis	0.000367	0.00175	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000366	0.00174	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000365	0.00174	CcSEcCtD
Fesoterodine—Mental disorder—Methotrexate—multiple sclerosis	0.000364	0.00173	CcSEcCtD
Fesoterodine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000358	0.00171	CcSEcCtD
Fesoterodine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000357	0.0017	CcSEcCtD
Fesoterodine—Dyspepsia—Betamethasone—multiple sclerosis	0.000357	0.0017	CcSEcCtD
Fesoterodine—Urticaria—Triamcinolone—multiple sclerosis	0.000355	0.00169	CcSEcCtD
Fesoterodine—Urticaria—Methylprednisolone—multiple sclerosis	0.000354	0.00169	CcSEcCtD
Fesoterodine—Dysgeusia—Methotrexate—multiple sclerosis	0.000354	0.00169	CcSEcCtD
Fesoterodine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000353	0.00168	CcSEcCtD
Fesoterodine—Nausea—Mitoxantrone—multiple sclerosis	0.000352	0.00168	CcSEcCtD
Fesoterodine—Infection—Prednisone—multiple sclerosis	0.000351	0.00167	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00035	0.00167	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00035	0.00167	CcSEcCtD
Fesoterodine—Back pain—Methotrexate—multiple sclerosis	0.00035	0.00167	CcSEcCtD
Fesoterodine—Fatigue—Betamethasone—multiple sclerosis	0.00035	0.00167	CcSEcCtD
Fesoterodine—Fatigue—Dexamethasone—multiple sclerosis	0.00035	0.00167	CcSEcCtD
Fesoterodine—Nervous system disorder—Prednisone—multiple sclerosis	0.000347	0.00165	CcSEcCtD
Fesoterodine—Tachycardia—Prednisone—multiple sclerosis	0.000345	0.00164	CcSEcCtD
Fesoterodine—Skin disorder—Prednisone—multiple sclerosis	0.000343	0.00163	CcSEcCtD
Fesoterodine—Vision blurred—Methotrexate—multiple sclerosis	0.000341	0.00162	CcSEcCtD
Fesoterodine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000334	0.00159	CcSEcCtD
Fesoterodine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000334	0.00159	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000332	0.00158	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000332	0.00158	CcSEcCtD
Fesoterodine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000329	0.00157	CcSEcCtD
Fesoterodine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000329	0.00157	CcSEcCtD
Fesoterodine—Vertigo—Methotrexate—multiple sclerosis	0.000325	0.00155	CcSEcCtD
Fesoterodine—Urticaria—Dexamethasone—multiple sclerosis	0.000322	0.00154	CcSEcCtD
Fesoterodine—Urticaria—Betamethasone—multiple sclerosis	0.000322	0.00154	CcSEcCtD
Fesoterodine—Dizziness—Prednisolone—multiple sclerosis	0.000322	0.00153	CcSEcCtD
Fesoterodine—Asthenia—Triamcinolone—multiple sclerosis	0.000321	0.00153	CcSEcCtD
Fesoterodine—Abdominal pain—Betamethasone—multiple sclerosis	0.000321	0.00153	CcSEcCtD
Fesoterodine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000321	0.00153	CcSEcCtD
Fesoterodine—Asthenia—Methylprednisolone—multiple sclerosis	0.00032	0.00152	CcSEcCtD
Fesoterodine—Insomnia—Prednisone—multiple sclerosis	0.00032	0.00152	CcSEcCtD
Fesoterodine—Pruritus—Triamcinolone—multiple sclerosis	0.000316	0.00151	CcSEcCtD
Fesoterodine—Cough—Methotrexate—multiple sclerosis	0.000316	0.0015	CcSEcCtD
Fesoterodine—Pruritus—Methylprednisolone—multiple sclerosis	0.000316	0.0015	CcSEcCtD
Fesoterodine—Dyspepsia—Prednisone—multiple sclerosis	0.000311	0.00148	CcSEcCtD
Fesoterodine—Chest pain—Methotrexate—multiple sclerosis	0.000308	0.00147	CcSEcCtD
Fesoterodine—Rash—Prednisolone—multiple sclerosis	0.000307	0.00146	CcSEcCtD
Fesoterodine—Dermatitis—Prednisolone—multiple sclerosis	0.000306	0.00146	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000306	0.00146	CcSEcCtD
Fesoterodine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000305	0.00145	CcSEcCtD
Fesoterodine—Fatigue—Prednisone—multiple sclerosis	0.000305	0.00145	CcSEcCtD
Fesoterodine—Headache—Prednisolone—multiple sclerosis	0.000305	0.00145	CcSEcCtD
Fesoterodine—Constipation—Prednisone—multiple sclerosis	0.000302	0.00144	CcSEcCtD
Fesoterodine—Confusional state—Methotrexate—multiple sclerosis	0.000298	0.00142	CcSEcCtD
Fesoterodine—Dizziness—Triamcinolone—multiple sclerosis	0.000296	0.00141	CcSEcCtD
Fesoterodine—Dizziness—Methylprednisolone—multiple sclerosis	0.000295	0.00141	CcSEcCtD
Fesoterodine—Infection—Methotrexate—multiple sclerosis	0.000293	0.0014	CcSEcCtD
Fesoterodine—Feeling abnormal—Prednisone—multiple sclerosis	0.000291	0.00139	CcSEcCtD
Fesoterodine—Asthenia—Dexamethasone—multiple sclerosis	0.000291	0.00139	CcSEcCtD
Fesoterodine—Asthenia—Betamethasone—multiple sclerosis	0.000291	0.00139	CcSEcCtD
Fesoterodine—Nervous system disorder—Methotrexate—multiple sclerosis	0.00029	0.00138	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000289	0.00138	CcSEcCtD
Fesoterodine—Nausea—Prednisolone—multiple sclerosis	0.000289	0.00138	CcSEcCtD
Fesoterodine—Pruritus—Dexamethasone—multiple sclerosis	0.000287	0.00137	CcSEcCtD
Fesoterodine—Pruritus—Betamethasone—multiple sclerosis	0.000287	0.00137	CcSEcCtD
Fesoterodine—Skin disorder—Methotrexate—multiple sclerosis	0.000287	0.00137	CcSEcCtD
Fesoterodine—Rash—Triamcinolone—multiple sclerosis	0.000282	0.00134	CcSEcCtD
Fesoterodine—Dermatitis—Triamcinolone—multiple sclerosis	0.000282	0.00134	CcSEcCtD
Fesoterodine—Rash—Methylprednisolone—multiple sclerosis	0.000281	0.00134	CcSEcCtD
Fesoterodine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000281	0.00134	CcSEcCtD
Fesoterodine—Urticaria—Prednisone—multiple sclerosis	0.000281	0.00134	CcSEcCtD
Fesoterodine—Headache—Triamcinolone—multiple sclerosis	0.00028	0.00133	CcSEcCtD
Fesoterodine—Headache—Methylprednisolone—multiple sclerosis	0.00028	0.00133	CcSEcCtD
Fesoterodine—Abdominal pain—Prednisone—multiple sclerosis	0.000279	0.00133	CcSEcCtD
Fesoterodine—Diarrhoea—Betamethasone—multiple sclerosis	0.000278	0.00132	CcSEcCtD
Fesoterodine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000278	0.00132	CcSEcCtD
Fesoterodine—Dizziness—Dexamethasone—multiple sclerosis	0.000268	0.00128	CcSEcCtD
Fesoterodine—Dizziness—Betamethasone—multiple sclerosis	0.000268	0.00128	CcSEcCtD
Fesoterodine—Insomnia—Methotrexate—multiple sclerosis	0.000267	0.00127	CcSEcCtD
Fesoterodine—Nausea—Triamcinolone—multiple sclerosis	0.000266	0.00126	CcSEcCtD
Fesoterodine—Nausea—Methylprednisolone—multiple sclerosis	0.000265	0.00126	CcSEcCtD
Fesoterodine—Somnolence—Methotrexate—multiple sclerosis	0.000263	0.00125	CcSEcCtD
Fesoterodine—Hypersensitivity—Prednisone—multiple sclerosis	0.00026	0.00124	CcSEcCtD
Fesoterodine—Dyspepsia—Methotrexate—multiple sclerosis	0.00026	0.00124	CcSEcCtD
Fesoterodine—Rash—Dexamethasone—multiple sclerosis	0.000256	0.00122	CcSEcCtD
Fesoterodine—Rash—Betamethasone—multiple sclerosis	0.000256	0.00122	CcSEcCtD
Fesoterodine—Dermatitis—Betamethasone—multiple sclerosis	0.000256	0.00122	CcSEcCtD
Fesoterodine—Dermatitis—Dexamethasone—multiple sclerosis	0.000256	0.00122	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000255	0.00121	CcSEcCtD
Fesoterodine—Fatigue—Methotrexate—multiple sclerosis	0.000255	0.00121	CcSEcCtD
Fesoterodine—Headache—Betamethasone—multiple sclerosis	0.000254	0.00121	CcSEcCtD
Fesoterodine—Headache—Dexamethasone—multiple sclerosis	0.000254	0.00121	CcSEcCtD
Fesoterodine—Asthenia—Prednisone—multiple sclerosis	0.000254	0.00121	CcSEcCtD
Fesoterodine—Pruritus—Prednisone—multiple sclerosis	0.00025	0.00119	CcSEcCtD
Fesoterodine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000243	0.00116	CcSEcCtD
Fesoterodine—Diarrhoea—Prednisone—multiple sclerosis	0.000242	0.00115	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000241	0.00115	CcSEcCtD
Fesoterodine—Nausea—Dexamethasone—multiple sclerosis	0.000241	0.00115	CcSEcCtD
Fesoterodine—Nausea—Betamethasone—multiple sclerosis	0.000241	0.00115	CcSEcCtD
Fesoterodine—Urticaria—Methotrexate—multiple sclerosis	0.000235	0.00112	CcSEcCtD
Fesoterodine—Dizziness—Prednisone—multiple sclerosis	0.000234	0.00111	CcSEcCtD
Fesoterodine—Abdominal pain—Methotrexate—multiple sclerosis	0.000233	0.00111	CcSEcCtD
Fesoterodine—Rash—Prednisone—multiple sclerosis	0.000223	0.00106	CcSEcCtD
Fesoterodine—Dermatitis—Prednisone—multiple sclerosis	0.000223	0.00106	CcSEcCtD
Fesoterodine—Headache—Prednisone—multiple sclerosis	0.000221	0.00105	CcSEcCtD
Fesoterodine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000218	0.00104	CcSEcCtD
Fesoterodine—Asthenia—Methotrexate—multiple sclerosis	0.000212	0.00101	CcSEcCtD
Fesoterodine—Nausea—Prednisone—multiple sclerosis	0.00021	0.001	CcSEcCtD
Fesoterodine—Pruritus—Methotrexate—multiple sclerosis	0.000209	0.000995	CcSEcCtD
Fesoterodine—Diarrhoea—Methotrexate—multiple sclerosis	0.000202	0.000962	CcSEcCtD
Fesoterodine—Dizziness—Methotrexate—multiple sclerosis	0.000195	0.00093	CcSEcCtD
Fesoterodine—Rash—Methotrexate—multiple sclerosis	0.000186	0.000887	CcSEcCtD
Fesoterodine—Dermatitis—Methotrexate—multiple sclerosis	0.000186	0.000886	CcSEcCtD
Fesoterodine—Headache—Methotrexate—multiple sclerosis	0.000185	0.000881	CcSEcCtD
Fesoterodine—Nausea—Methotrexate—multiple sclerosis	0.000175	0.000835	CcSEcCtD
Fesoterodine—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	4.19e-05	0.000604	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	4.17e-05	0.000601	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	4.16e-05	0.0006	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.15e-05	0.000598	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	4.14e-05	0.000596	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.14e-05	0.000596	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	4.12e-05	0.000594	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	4.08e-05	0.000589	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCL3—multiple sclerosis	4.08e-05	0.000589	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.07e-05	0.000586	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	4.05e-05	0.000583	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	4.03e-05	0.000582	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CCR5—multiple sclerosis	4.03e-05	0.000581	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	4e-05	0.000576	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.97e-05	0.000573	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.97e-05	0.000573	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL2RA—multiple sclerosis	3.97e-05	0.000572	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PTGER4—multiple sclerosis	3.93e-05	0.000567	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	3.91e-05	0.000564	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	3.89e-05	0.000561	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	3.88e-05	0.000559	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PGR—multiple sclerosis	3.87e-05	0.000558	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	3.86e-05	0.000557	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	3.86e-05	0.000557	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	3.86e-05	0.000556	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.86e-05	0.000556	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GPC5—multiple sclerosis	3.86e-05	0.000556	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	3.85e-05	0.000555	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	3.85e-05	0.000555	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	3.84e-05	0.000554	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	3.84e-05	0.000554	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	3.81e-05	0.00055	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	3.81e-05	0.00055	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.81e-05	0.000549	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	3.8e-05	0.000548	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCR3—multiple sclerosis	3.8e-05	0.000547	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	3.76e-05	0.000543	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CD28—multiple sclerosis	3.76e-05	0.000542	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PGR—multiple sclerosis	3.71e-05	0.000534	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCR2—multiple sclerosis	3.69e-05	0.000532	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SRM—multiple sclerosis	3.69e-05	0.000532	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	3.64e-05	0.000524	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.63e-05	0.000524	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CD28—multiple sclerosis	3.6e-05	0.000519	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	3.54e-05	0.00051	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	3.5e-05	0.000505	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	3.49e-05	0.000503	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—POMC—multiple sclerosis	3.47e-05	0.0005	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	3.46e-05	0.000498	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.42e-05	0.000493	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CNR1—multiple sclerosis	3.41e-05	0.000491	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	3.36e-05	0.000485	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	3.32e-05	0.000479	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	3.32e-05	0.000479	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	3.31e-05	0.000477	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	3.28e-05	0.000472	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	3.26e-05	0.00047	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—RRM1—multiple sclerosis	3.2e-05	0.000461	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.19e-05	0.00046	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.18e-05	0.000458	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	3.15e-05	0.000454	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	3.08e-05	0.000444	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	3.07e-05	0.000442	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	3.01e-05	0.000435	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	3.01e-05	0.000435	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.01e-05	0.000434	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	3.01e-05	0.000433	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	2.99e-05	0.000431	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	2.98e-05	0.00043	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	2.98e-05	0.000429	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	2.95e-05	0.000426	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	2.95e-05	0.000425	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.95e-05	0.000425	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.95e-05	0.000425	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.94e-05	0.000424	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	2.94e-05	0.000424	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	2.94e-05	0.000424	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.91e-05	0.000419	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—BCHE—multiple sclerosis	2.89e-05	0.000417	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.88e-05	0.000416	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	2.8e-05	0.000403	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	2.75e-05	0.000397	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.75e-05	0.000396	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	2.74e-05	0.000396	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	2.72e-05	0.000392	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	2.72e-05	0.000392	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	2.71e-05	0.00039	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CD86—multiple sclerosis	2.68e-05	0.000387	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	2.68e-05	0.000386	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	2.68e-05	0.000386	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	2.68e-05	0.000386	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	2.67e-05	0.000385	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	2.65e-05	0.000382	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	2.64e-05	0.000381	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	2.64e-05	0.000381	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	2.64e-05	0.000381	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	2.62e-05	0.000377	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PGR—multiple sclerosis	2.61e-05	0.000376	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PGR—multiple sclerosis	2.6e-05	0.000375	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.6e-05	0.000374	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.6e-05	0.000374	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	2.58e-05	0.000371	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CD86—multiple sclerosis	2.57e-05	0.00037	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	2.56e-05	0.000369	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	2.56e-05	0.000369	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	2.55e-05	0.000368	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CD28—multiple sclerosis	2.54e-05	0.000366	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	2.53e-05	0.000365	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CD28—multiple sclerosis	2.53e-05	0.000364	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	2.53e-05	0.000364	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	2.5e-05	0.000361	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	2.49e-05	0.000359	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	2.48e-05	0.000358	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	2.46e-05	0.000354	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	2.45e-05	0.000354	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	2.45e-05	0.000353	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	2.38e-05	0.000343	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.38e-05	0.000343	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	2.35e-05	0.000338	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	2.34e-05	0.000338	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	2.34e-05	0.000337	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	2.33e-05	0.000336	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	2.33e-05	0.000336	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	2.31e-05	0.000333	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	2.3e-05	0.000331	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	2.29e-05	0.00033	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	2.28e-05	0.000328	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	2.27e-05	0.000327	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	2.25e-05	0.000324	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	2.23e-05	0.000321	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—APOE—multiple sclerosis	2.16e-05	0.000312	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	2.12e-05	0.000306	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	2.12e-05	0.000305	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	2.1e-05	0.000302	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	2.08e-05	0.000299	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—APOE—multiple sclerosis	2.07e-05	0.000299	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	2.07e-05	0.000298	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	2.07e-05	0.000298	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	2.06e-05	0.000297	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	2.05e-05	0.000296	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.04e-05	0.000294	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.000284	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CD80—multiple sclerosis	1.96e-05	0.000282	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.89e-05	0.000272	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	1.88e-05	0.000271	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CD80—multiple sclerosis	1.87e-05	0.00027	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.86e-05	0.000268	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—POMC—multiple sclerosis	1.86e-05	0.000268	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.85e-05	0.000266	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.84e-05	0.000265	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	1.82e-05	0.000262	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	1.81e-05	0.000261	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CD86—multiple sclerosis	1.8e-05	0.00026	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.79e-05	0.000257	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—POMC—multiple sclerosis	1.78e-05	0.000257	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1.78e-05	0.000257	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	1.78e-05	0.000257	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	1.78e-05	0.000256	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.76e-05	0.000253	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	1.74e-05	0.000251	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—APOE—multiple sclerosis	1.74e-05	0.000251	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.73e-05	0.000249	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.73e-05	0.000249	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	1.72e-05	0.000248	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.71e-05	0.000246	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	1.7e-05	0.000246	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	1.65e-05	0.000238	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	1.65e-05	0.000238	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	1.64e-05	0.000237	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.63e-05	0.000235	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	1.6e-05	0.000231	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	1.6e-05	0.000231	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.58e-05	0.000228	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	1.58e-05	0.000228	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.58e-05	0.000228	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	1.58e-05	0.000227	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	1.57e-05	0.000226	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	1.56e-05	0.000226	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.56e-05	0.000225	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.55e-05	0.000223	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—POMC—multiple sclerosis	1.49e-05	0.000215	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	1.46e-05	0.00021	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.46e-05	0.00021	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.44e-05	0.000208	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	1.37e-05	0.000198	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	1.37e-05	0.000197	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALB—multiple sclerosis	1.36e-05	0.000196	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.32e-05	0.00019	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.32e-05	0.00019	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.32e-05	0.00019	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.31e-05	0.000189	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.3e-05	0.000188	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	1.3e-05	0.000188	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.25e-05	0.000181	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.25e-05	0.00018	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.25e-05	0.00018	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.24e-05	0.000178	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.23e-05	0.000177	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.22e-05	0.000176	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.21e-05	0.000175	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.2e-05	0.000173	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.2e-05	0.000172	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.18e-05	0.000171	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	1.16e-05	0.000167	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000163	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.11e-05	0.000161	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.11e-05	0.00016	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.11e-05	0.00016	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOE—multiple sclerosis	1.1e-05	0.000159	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.1e-05	0.000159	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	1.08e-05	0.000155	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	1.07e-05	0.000155	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	1.05e-05	0.000152	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.04e-05	0.00015	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.03e-05	0.000148	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.03e-05	0.000148	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.01e-05	0.000145	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—POMC—multiple sclerosis	9.49e-06	0.000137	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	9.27e-06	0.000134	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	9.24e-06	0.000133	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	9.22e-06	0.000133	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	9.19e-06	0.000133	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	9.15e-06	0.000132	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	9.11e-06	0.000131	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—POMC—multiple sclerosis	8.94e-06	0.000129	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	8.77e-06	0.000126	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	8.75e-06	0.000126	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	8.66e-06	0.000125	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALB—multiple sclerosis	8.65e-06	0.000125	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALB—multiple sclerosis	8.15e-06	0.000117	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	8.08e-06	0.000116	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	7.8e-06	0.000112	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	7.78e-06	0.000112	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—multiple sclerosis	7.74e-06	0.000112	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	7.7e-06	0.000111	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	7.25e-06	0.000104	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	7.23e-06	0.000104	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	7.23e-06	0.000104	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	7.21e-06	0.000104	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	7.16e-06	0.000103	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	7.14e-06	0.000103	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	7.09e-06	0.000102	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	7.07e-06	0.000102	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	7e-06	0.000101	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOE—multiple sclerosis	6.8e-06	9.81e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—POMC—multiple sclerosis	5.84e-06	8.42e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	5.45e-06	7.85e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	5.43e-06	7.83e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	5.38e-06	7.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALB—multiple sclerosis	5.33e-06	7.68e-05	CbGpPWpGaD
